MicroRNA-143 inhibits proliferation and migration of prostate cancer cells

References

• Aghajani, M., et al., 2020. CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel. Molecular biology reports. doi:10.1007/s11033-020-05411-9
   PubMed Web of Science ®Google Scholar
• Bhayani, M.K., Calin, G.A., and Lai, S.Y., 2012. Functional relevance of miRNA sequences in human disease. Mutation research, 731 (1–2), 14–19.
   PubMed Web of Science ®Google Scholar
• Che, Y., et al., 2019. Exosomes derived from miR-143-overexpressing MSCs inhibit cell migration and invasion in human prostate cancer by downregulating TFF3. Molecular therapy nucleic acids, 18, 232–244.
   PubMedGoogle Scholar
• Chen, X., et al., 2009. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene, 28 (10), 1385–1392.
   PubMed Web of Science ®Google Scholar
• Clapé, C., et al., 2009. miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice. PLoS one, 4 (10), e7542
   PubMed Web of Science ®Google Scholar
• Croce, C.M., 2009. Causes and consequences of microRNA dysregulation in cancer. Nature reviews. Genetics, 10 (10), 704–714.
   PubMed Web of Science ®Google Scholar
• Ferlay, J., et al., 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer, 127 (12), 2893–2917.
   PubMed Web of Science ®Google Scholar
• Fu, X., et al., 2010. The activity and expression of microRNAs in prostate cancers. Molecular bioSystems, 6 (12), 2561–2572.
   PubMedGoogle Scholar
• Gerlinger, M., et al., 2012. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. The New England journal of medicine, 366 (10), 883–892.
   PubMed Web of Science ®Google Scholar
• Hajiasgharzadeh, K., et al., 2020. Alpha7 nicotinic acetylcholine receptor mediates nicotine-induced apoptosis and cell cycle arrest of hepatocellular carcinoma HepG2 cells. Advanced pharmaceutical bulletin, 10 (1), 65–71.
   PubMed Web of Science ®Google Scholar
• Iio, A., et al., 2010. Identification of non-coding RNAs embracing microRNA-143/145 cluster. Molecular cancer, 9 (1), 136
   PubMedGoogle Scholar
• Iio, A., et al., 2013. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells. Biochimica et biophysica acta, 1829 (10), 1102–1110.
   PubMed Web of Science ®Google Scholar
• Karami, H., et al., 2013. siRNA-mediated silencing of Survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Asian Pacific journal of cancer prevention: APJCP, 14 (12), 7719–7724.
   PubMedGoogle Scholar
• Ma, Q., et al., 2013. MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. International journal of biological sciences, 9 (7), 680–692.
   PubMed Web of Science ®Google Scholar
• Mansoori, B., et al., 2015. Micro-RNAs: the new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Cellular and molecular biology (Noisy-le-Grand, France), 61 (5), 1–10.
   PubMed Web of Science ®Google Scholar
• Mohammadi, A., et al., 2016. Urtica dioica dichloromethane extract induce apoptosis from intrinsic pathway on human prostate cancer cells (PC3). Cellular and molecular biology (Noisy-le-Grand, France), 62 (3), 78–83.
   PubMed Web of Science ®Google Scholar
• Ng, E.K.O., et al., 2009. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. British journal of cancer, 101 (4), 699–706.
   PubMed Web of Science ®Google Scholar
• Pecorino, L., 2012. Molecular biology of cancer: mechanisms, targets, and therapeutics. Oxford: Oxford university press.
   Google Scholar
• Peng, X., et al., 2011. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS one, 6 (5), e20341
   PubMed Web of Science ®Google Scholar
• Reid, G., Kirschner, M.B., and van Zandwijk, N., 2011. Circulating microRNAs: association with disease and potential use as biomarkers. Critical reviews in oncology/hematology, 80 (2), 193–208.
   PubMed Web of Science ®Google Scholar
• Roodman, G.D., 2004. Mechanisms of bone metastasis. The New England journal of medicine, 350 (16), 1655–1664.
   PubMed Web of Science ®Google Scholar
• Rubin, M.A., et al., 2000. Rapid (‘warm’) autopsy study for procurement of metastatic prostate cancer. Clinical cancer research: an official journal of the American association for cancer research, 6 (3), 1038–1045.
   PubMed Web of Science ®Google Scholar
• Sadeghiyeh, N., et al., 2019. MicroRNA-145 replacement effect on growth and migration inhibition in lung cancer cell line. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 111, 460–467.
   PubMed Web of Science ®Google Scholar
• Shajari, N., et al., 2018. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression. Artificial cells, nanomedicine, and biotechnology, 46 (7), 1495–1504.
   PubMed Web of Science ®Google Scholar
• Shenouda, S.K., and Alahari, S.K., 2009. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer metastasis reviews, 28 (3–4), 369–378.
   PubMed Web of Science ®Google Scholar
• van Beijnum, J.R., et al., 2017. miRNAs: micro-managers of anticancer combination therapies. Angiogenesis, 20 (2), 269–285.
   PubMed Web of Science ®Google Scholar
• Wang, C.-J., et al., 2009. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Disease markers, 26 (1), 27–34.
   PubMed Web of Science ®Google Scholar
• Wu, D., et al., 2013. MicroRNA-143 inhibits cell migration and invasion by targeting matrix metalloproteinase 13 in prostate cancer. Molecular medicine reports, 8 (2), 626–630.
   PubMed Web of Science ®Google Scholar
• Zhou, P., Chen, W.-G., and Li, X.-W., 2015. MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer. American journal of cancer research, 5 (6), 2056–2063.
   PubMed Web of Science ®Google Scholar